Design‐oriented regression models for H2O2 decontamination processes in sterile drug product manufacturing considering rapidity and sterility

ABSTRACT We developed regression models for designing rapid and effective H2O2 decontamination processes in the manufacturing of sterile drug products such as injectables. Decontamination, which is typically performed by using H2O2, is a critical changeover process used to establish a sterile environment for filling products. In the process, there is a trade‐off relationship between the duration of the process and the level of sterility assurance that needs to be considered in the design. Our model defines these two items as objective functions and the parameters describing the profile of H2O2 injection and the initial humidity as design variables. Our model also considers aeration, i.e., removal of H2O2 from the environment, as a part of the entire process. This design‐oriented modeling considering the entire process is the novelty of the work. Experiments were performed using an industrial isolator to develop and validate a set of regression models that describe the relationship between the design variables and the objective functions. In the application of the model, Pareto‐optimal conditions could be indicated given the target H2O2 concentration in aeration, which is useful for the makers of drugs and/or isolators for designing decontamination processes.

[1]  Christian Hertel,et al.  The Influence of Humidity, Hydrogen Peroxide Concentration, and Condensation on the Inactivation of Geobacillus stearothermophilus Spores with Hydrogen Peroxide Vapor , 2008, Journal of Pharmaceutical Innovation.

[2]  M. Ierapetritou,et al.  A Novel Surrogate-Based Optimization Method for Black-Box Simulation with Heteroscedastic Noise , 2017 .

[3]  J. Gajdziok,et al.  Experimental Design for Determination of Effects of Superdisintegrant Combinations on Liquisolid System Properties. , 2017, Journal of pharmaceutical sciences.

[4]  W. Rutala,et al.  Monitoring and improving the effectiveness of surface cleaning and disinfection. , 2016, American journal of infection control.

[5]  A. Sterchi Hydrogen peroxide in pharma-isolators, investigations about bahavior, measurement and effects , 2001 .

[6]  J. Khinast,et al.  Quantifying Absorption Effects during Hydrogen Peroxide Decontamination , 2011, Journal of Pharmaceutical Innovation.

[7]  Zorica Djuric,et al.  Modeling in the quality by design environment: Regulatory requirements and recommendations for design space and control strategy appointment. , 2017, International journal of pharmaceutics.

[8]  M. Otsuka,et al.  Modeling of feed-forward control using the partial least squares regression method in the tablet compression process. , 2017, International journal of pharmaceutics.

[9]  J. Remon,et al.  Near-Infrared (NIR) Monitoring of H2O2 Vapor Concentration During Vapor Hydrogen Peroxide (VHP) Sterilisation , 1997, Pharmaceutical Research.

[10]  Wei Wang,et al.  Impact of residual impurities and contaminants on protein stability. , 2014, Journal of pharmaceutical sciences.

[11]  J. Khinast,et al.  The Engineering of Hydrogen Peroxide Decontamination Systems , 2009, Journal of Pharmaceutical Innovation.

[12]  V. Sigwarth,et al.  Development and quantification of H2O2 decontamination cycles. , 2000, PDA journal of pharmaceutical science and technology.

[13]  Y. J. Wang,et al.  Oxidation of protein by vaporized sanitizing agents. , 2004, PDA journal of pharmaceutical science and technology.

[14]  A K Krishna,et al.  Isolation Technology for Research and Development Applications: From Concept to Production , 2000, Pharmaceutical development and technology.

[15]  J. Rantanen,et al.  The Future of Pharmaceutical Manufacturing Sciences , 2015, Journal of pharmaceutical sciences.

[16]  G. Bearman,et al.  Touchless Technologies for Decontamination in the Hospital: a Review of Hydrogen Peroxide and UV Devices , 2015, Current Infectious Disease Reports.

[17]  Hirokazu Sugiyama,et al.  Uncertainty‐conscious methodology for process performance assessment in biopharmaceutical drug product manufacturing , 2018 .